Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach

Somatostatin receptors are clinically validated GPCR biomarkers for diagnosis and treatment of various neuroendocrine tumors (NET). Among the five somatostatin receptors, SST2 and SST3 are associated with apoptosis and cell cycle arrest, making these receptor subtypes better differentiated targets i...

Descripción completa

Detalles Bibliográficos
Autores principales: Oron-Herman, Mor, Kirmayer, David, Lupp, Amelie, Schulz, Stefan, Kostenich, Genady, Afargan, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682014/
https://www.ncbi.nlm.nih.gov/pubmed/38012197
http://dx.doi.org/10.1038/s41598-023-47877-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682014/
https://www.ncbi.nlm.nih.gov/pubmed/38012197
http://dx.doi.org/10.1038/s41598-023-47877-0

Ejemplares similares